BTL Aesthetics has been recognised with two industry awards, winning the Best Non-Invasive Body Shaping Solutions Manufacturer 2024 at The Australian Made Awards, presented by APAC Insider, and the Best Wellness Device at the 2024 Spa & Wellness Awards.

APAC Insider is a leading platform for business insights in the Asia-Pacific region. The Australian Made Awards celebrates the innovation, growth and dynamic nature of the business and manufacturing sectors across Australia – from emerging start-ups to established industry leaders.

In addition, BTL’s EMSELLA device was awarded Best Wellness Device at the 2024 Spa & Wellness Awards. The Spa & Wellness Awards recognise people and businesses for their outstanding efforts in the spa, health, beauty and wellness tourism space. The Awards honour remarkable contributions, be it in the form of impactful initiatives, superior products or exceptional services.

 

EMSELLA offers a breakthrough treatment for incontinence and intimate wellbeing. This innovative technology uses HIFEM energy to stimulate the entire pelvic floor area. The treatment is completely non-invasive. A single session causes thousands of supramaximal pelvic floor muscle contractions, which are important in muscle re-education, and improvement of intimate well-being for women and men.

Gareth Pepper, National Sales Director at BTL, shared, ‘We are honoured to receive not just one, but two prestigious awards from APAC Insider and Spa & Wellness for 2024. This recognition is a fitting culmination of an extraordinary year for BTL. Despite challenges such as the pandemic and economic shifts, BTL Aesthetics has continued to thrive, with over 500 devices installed across the region.

‘This year has been particularly special as we celebrated two significant milestones: five years of excellence in Australia and New Zealand, and 30 years of global leadership in non-invasive aesthetic solutions. We are proud that APAC Insider and Spa & Wellness have acknowledged our growth and achievements.’

Previous articleWorld-first tag sheds new light on ‘disordered’ proteins in Parkinson’s
Next articleStool transplant aids early-stage Parkinson’s